About the Institutional Review Board (IRB)
The IRB is a standing committee established at KHCC in 2003. It aims to protect the rights and welfare of human research subjects recruited to participate in research conducted at KHCC. It primarily accomplishes this by reviewing proposals for research and determining the level of risk.
Research activity approval
- All research activity involving human subjects (direct interaction/intervention or indirect through medical data, patients' samples) conducted at, by or under the auspice of KHCC, whether funded or not and whether conducted by administrators, faculty, staff, or students, must be reviewed and approved by the IRB before the research begins.
- The IRB has the authority to approve, require modifications, or disapprove the proposed research projects that fall within its jurisdiction as specified by KHCC's policies and IRB manual.
Abides by international standards and regulations
- KHCC-IRB functions in accordance with national and international regulations including Good Clinical Practice (GCP), Helsinki Declaration and the International Conference on Harmonization (ICH) guidelines on clinical trials.
- It is approved by the Jordan Food and Drug Administration (JFDA)
- It is registered with the Federal Wide Assurance (FWA) that is issued by the United States Office of Human Subject Protection in the Department of Health and Human Services.
Who is on the board?
- IRB is composed of faculty members, administrators, community members and lawyers divided into regular and alternate members.
- An IRB office coordinator oversees and streamlines the whole submission process and acts as a liaison between the IRB chairperson and members, the investigators and the Office of Scientific affairs and Research .
- The full IRB board meets bimonthly to review studies and discuss various administrative issues.
For more information, please contact IRB at:
Tel: (+962-6) 53 00 460 extension 1669